增强剂驱动的基因激活的机制
Joyce Vriend1,2, Ruud Delwel1,2, Dorien Pastoors1,2
1Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
International journal of cancer
|January 24, 2025
概括
增强器劫持通过增加MECOM表达导致攻击性急性髓性白血病 (AML). 了解增强剂放松管制是开发新的AML治疗方法的关键.
科学领域:
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 侵袭性急性髓性白血病 (AML) 亚型是由增强器劫持驱动的,导致MECOM过度表达.
- 染色体重排如inv(3) /t(3;3) 劫持了GATA2增强剂,而其他重排则涉及不同的造血基因增强剂.
- BCL11B可以劫持与MECOM相同的增强剂,这表明增强剂放松管制的作用更广泛.
研究的目的:
- 调查AML中增强剂放松管制的机制.
- 探索超级增强剂在瘤发生过程中的作用.
- 确定AML和其他由增强剂放松调节驱动的癌症的潜在治疗点.
主要方法:
- 对AML染色体重组的分析.
- 对增强剂活性和基因表达的研究.
- 研究TAD边界干扰和新的超级增强器形成.
主要成果:
- 确定增强剂劫持是AML中MECOM过度表达的原因.
- 证明了由MECOM劫持的增强剂也可以被BCL11B.劫持.
- 建议TAD边界干扰和超级增强剂可以在没有转位介导增强剂劫持的情况下驱动AML的瘤发生.
结论:
- 增强器放松调节是AML和其他恶性瘤中瘤发生的重要驱动因素.
- 对增强剂放松调节和超增强剂活性的机械洞察对于开发新型癌症疗法至关重要.
- 向增强剂放松管制为治疗AML和相关癌症提供了一个有希望的途径.
相关概念视频
Cancer-Critical Genes I: Proto-oncogenes
8.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
Mechanisms of Retrovirus-induced Cancers
5.0K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.0K
Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K
Amplifying Signals via Enzymatic Cascade
8.3K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.3K
MAPK Signaling Cascades
5.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K


